Physician profile
Trevor Wright
NPI 1992299283
$4,868.24
in general payments reported to CMS, 2019-2025
50 companies · $87.46 in 2025
The $87.46 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,078 · 2022: $271 · 2023: $311 · 2024: $121 · 2025: $87.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,273.36 | 2021 | |
| Abbvie INC. | $475.33 | 2021-2023 | |
| Ucb, INC. | $400.38 | 2021-2024 | Briviact |
| Eisai INC. | $254.19 | 2021 | |
| Biogen, INC. | $202.52 | 2021 | |
| Mdd US Operations, LLC | $194.75 | 2021 | |
| Neurelis, INC. | $191.15 | 2021 | |
| Sunovion Pharmaceuticals INC. | $144.01 | 2021 | |
| Allergan, INC. | $113.15 | 2021 | |
| Janssen Pharmaceuticals, INC | $104.47 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $101.71 | 2021-2024 | Andexxa |
| Upsher-Smith Laboratories LLC | $89.29 | 2021 | |
| Acadia Pharmaceuticals INC | $77.01 | 2021 | |
| Celgene Corporation | $75.27 | 2021 | |
| Pfizer INC. | $71.41 | 2021-2023 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trevor Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.